Characteristics of the 14 studies included in the meta-analysis to assess the risk of new cardiovascular events in patients with RA
Author (year) | Country | N | Mean disease duration at entry (years) | Person-years at risk | Enrolment period | CVD events (n) | CVD included | Sample type | Inception cohort | Subjects' mean age at entry (years) | Female (%) | RA definition | Outcome ascertainment | Quality score |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gabriel et al (1999)* | USA | 450 | 0 (@) | NAV | 1965–1995 | 113 | AMI, CVA, CHF | Community-based | Yes | 64.1 | 74 | ARA | MR | 14 |
Del Rincón et al (2001) | USA | 234 | 10 (#) | 252 | 1996 | 15 | AMI, CVA | Clinic-based | No | 56 | 62.3 | ACR | MR | 10 |
Watson et al (2003) | UK | 11 633 | NAV | NAV | 1987 to last encounter | 807 | AMI, CVA | Community-based | No | NAV | 70 | ICD-9 codes | 9 | |
Solomon et al (2003) | USA | 407 | NAV | 6259 | 1978–1996 | 24 | AMI, CVA | Community-based | Yes | 58 | 100 | ACR | MR | 14 |
Turesson et al (2004) | Sweden | 1022 | NAV | 2300 | 1997 | 54 | AMI, CVA | Community-based | No | NAV | 74 | ACR | ICD-9/10 codes | 7 |
Fischer et al (2004)† | UK | 208 | NAV | NAV | 1995–2002 | 208 | AMI | Community-based | No | NAV | 62 | Read codes | Read codes | 11 |
Goodson et al (2005) | UK | 515 | NAV | 3173 | 1981–1996 | 134 | AMI, CVA | Clinic-based | Yes | 56.2 | 72 | Rheumatologist's opinion | ICD-9 codes | 9 |
Maradit-Kremers et al (2005)* | USA | 603 | 0 (@) | 8672 | 1955–1995 | 40 | AMI | Community-based | Yes | 58 | 73 | ACR | MR | 14 |
Nicola et al (2005)* | USA | 575 | 0 (@) | 8107 | 1955–1995 | 575 | CHF | Community-based | Yes | 57.1 | 73 | ACR | Framingham criteria | 14 |
Solomon et al (2006) | Canada | 24 413 | NAV | 68 525 | 1999–2003 | 828 | AMI, CVA | Community-based | No | NAV | 74 | ICD-9 codes | ICD-9/10 codes | 8 |
Södergren et al (2007)† | Sweden | 640 | NAV | NAV | 1979 | 35 | AMI | Clinic-based | No | NAV | 68 | Seropositive RA | MONICA definition | 8 |
Nadareishvili et al (2008)† | USA | 226 | NAV | NAV | 1999–2006 | 226 | CVA | Community-based | No | NAV | 87 | Rheumatologist's opinion | MR | 7 |
Bergström et al (2009)‡ | ||||||||||||||
1978 cohort | Sweden | 148 | 13.9 | 1184 | 1978 | 31 | AMI | Community-based | No | 46.3 | 79 | ARA | ICD-8,9,10 codes | 10 |
1995 cohort | Sweden | 161 | 13.3 | 1288 | 1995 | 37 | CVA | 48.3 | 78 | ARA | ||||
Peters et al (2009) | Netherlands | 312 | 7 | 848 | 2001–2002 | 28 | CVD | Clinic-based | No | 63 | 65 | ACR | MR | 10 |
↵* Studies from the same cohort.
↵† Case–control study.
↵‡ Study with two cohorts.
↵# Disease duration not mentioned, but from the article we inferred at least 10 years.
↵@ Inception cohort, we assumed time 0 to entry cohort.
ACR, American College of Rheumatology; AMI, acute myocardial infarction; ARA, American Rheumatology Association; CHF, congestive heart failure; CVA, cerebrovascular accidents; CVD, cardiovascular disease; ICD, International Classification for Diseases; MONICA, multinational MONItoring of trends and determinants in CArdiovascular disease; MR, medical record; NAV, not available; RA, rheumatoid arthritis.